Home > Insider Trading > Filing (0000950170-24-114788)

Filing Details

Accession Number:: 0000950170-24-114788
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-15 18:00:16
Reporting Period:: 2024-10-15

Accepted Time:: 2024-10-15 18:00:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736730	Camp4 Therapeutics Corp	CAMP	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1438226	W Amy Schulman	One Marina Park Drive, 8Th Floor Boston MA 02210	No	No	No	No
1611189	Polaris Partners Vii, L.p.	One Marina Park Drive, 8Th Floor Boston MA 02210	No	No	No	No
1615991	Polaris Entrepreneurs' Fund Vii, L.p.	One Marina Park Drive 8Th Floor Boston MA 02210	No	No	No	No
1678203	Polaris Management Co. Vii, L.l.c.	One Marina Park Drive, 8Th Floor Boston MA 02210	No	No	No	No
1910575	Polaris Partners Gp X, L.l.c.	One Marina Park Drive, 8Th Floor Boston MA 02210	No	No	No	No
1910577	Polaris Partners X, L.p.	One Marina Park Drive, 8Th Floor Boston MA 02210	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-15	1,250,061	$0.00	1,250,061	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2024-10-15	87,448	$0.00	87,448	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2024-10-15	353,718	$0.00	1,603,779	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2024-10-15	24,745	$0.00	112,193	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2024-10-15	909,090	$11.00	909,090	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Prime Preferred Stock	Disposition	2024-10-15	14,020,475	$0.00	1,250,061	$0.00
Common Stock	Series A Prime Preferred Stock	Disposition	2024-10-15	980,829	$0.00	87,448	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	3,967,234	$0.00	353,718	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-10-15	277,536	$0.00	24,745	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The reported securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, Amir Nashat, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "PMC VII Managing Members") are the managing members of PMC VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
The reported securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PEF VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The reported securities are owned directly by Polaris Partners X, L.P. ("PP X"). Polaris Partners GP X, L.L.C. ("PPGP X") is the general partner of PP X. Each of Amy Schulman and Brian Chee are the managing members of PPGP X (the "PPGP X Managing Members"). Amir Nashat ("Mr. Nashat"), a member of the Issuer's board of directors, is an interest holder of PPGP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat, in their respective capacities with respect to PPGP X, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PPGP X Managing Members, Mr. Nashat or PPGP X is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.